ATTO Earnings Date: Dec 2, 2026 (Estimated) — Attovia Therapeutics, Inc.
NASDAQ
Updated
When is ATTO's next earnings date?
Attovia Therapeutics, Inc. (ATTO) is expected to report earnings on Wednesday, December 2, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.56 on revenue of $450,000.
How did ATTO do in its last earnings report?
In its most recent report on Sep 2, 2026 (Q2 2026), Attovia Therapeutics, Inc. posted EPS of -$4.88 versus the -$0.65 estimate, a miss of 5.6%. Revenue was $450,000 against a $316,667 estimate. The stock's 1-day post-earnings move was +4.1%.
How much does ATTO stock move after earnings?
ATTO beat EPS estimates in 0 of its last 1 reported quarter.
About Attovia Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 | Q2 2026 | -0.65 | -4.88 | -5.63% | $450,000 | ❌ Miss | +4.10% | +2.88% | -19.94% |
Showing last 1 quarters.